159 related articles for article (PubMed ID: 6366418)
1. Phencyclidine-induced inhibition of striatal acetylcholine release: comparisons with mu, kappa, and sigma opiate agonists.
Leventer SM; Johnson KM
Life Sci; 1984 Feb; 34(8):793-801. PubMed ID: 6366418
[TBL] [Abstract][Full Text] [Related]
2. Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice.
Hiramatsu M; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 May; 9(5):466-72. PubMed ID: 3020223
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist.
Slifer BL; Dykstra LA
Life Sci; 1987 Jan; 40(4):343-9. PubMed ID: 3027481
[TBL] [Abstract][Full Text] [Related]
4. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
Pechnick R; George R; Poland RE
J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
[TBL] [Abstract][Full Text] [Related]
5. Different effects of ethylketocyclazocine on phencyclidine- and N-allylnormetazocine-induced stereotyped behaviors in rats.
Hiramatsu M; Nabeshima T; Furukawa H; Kameyama T
Pharmacol Biochem Behav; 1987 Dec; 28(4):489-94. PubMed ID: 2893389
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
Snell LD; Johnson KM
J Pharmacol Exp Ther; 1985 Oct; 235(1):50-7. PubMed ID: 2864436
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
[TBL] [Abstract][Full Text] [Related]
8. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
[TBL] [Abstract][Full Text] [Related]
9. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
10. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
Eisenberg RM
J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
[TBL] [Abstract][Full Text] [Related]
11. Effects of phencyclidine on the release of radioactivity from rat striatal slices labeled with [3H]choline.
Leventer SM; Johnson KM
J Pharmacol Exp Ther; 1983 May; 225(2):332-6. PubMed ID: 6842397
[TBL] [Abstract][Full Text] [Related]
12. Blockade of long-term potentiation by phencyclidine and sigma opiates in the hippocampus in vivo and in vitro.
Stringer JL; Greenfield LJ; Hackett JT; Guyenet PG
Brain Res; 1983 Nov; 280(1):127-38. PubMed ID: 6317141
[TBL] [Abstract][Full Text] [Related]
13. Involvement of opioid receptors in phencyclidine-induced enhancement of brain histamine turnover in mice.
Itoh Y; Oishi R; Nishibori M; Saeki K
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):285-9. PubMed ID: 2884577
[TBL] [Abstract][Full Text] [Related]
14. The effect of two different buffers on the high affinity 3H-ethylketocyclazocine and 3H-SKF10047 binding to guinea pig brain membranes.
Grynne BH; Maurset AR; Holmen AT; Enger M
Acta Pharmacol Toxicol (Copenh); 1984 Mar; 54(3):195-200. PubMed ID: 6144235
[TBL] [Abstract][Full Text] [Related]
15. Phencyclidine-induced stereotyped behaviors after injection of ethylketocyclazocine, Mr 2266 and naltrexone in rats.
Nabeshima T; Hiramatsu M; Kameyama T
Brain Res; 1986 Jul; 378(2):234-9. PubMed ID: 3015356
[TBL] [Abstract][Full Text] [Related]
16. Receptors and secretory actions of sigma/phencyclidine agonists in anterior pituitary cells.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Dec; 121(6):2044-54. PubMed ID: 2824179
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological effects of cyclazocine on rat cerebellar Purkinje neurons: comparison with phencyclidine.
Kim M; Pang K; Freedman R; Palmer M
Alcohol Drug Res; 1985-1986; 6(1):23-36. PubMed ID: 4074470
[TBL] [Abstract][Full Text] [Related]
18. Phencyclidine (PCP)-like inhibition of N-methyl-D-aspartate-evoked striatal acetylcholine release, H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylator.
Snell LD; Johnson KM; Yi SJ; Lessor RA; Rice KC; Jacobson AE
Life Sci; 1987 Dec; 41(24):2645-54. PubMed ID: 2826948
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors.
Zukin SR; Brady KT; Slifer BL; Balster RL
Brain Res; 1984 Feb; 294(1):174-7. PubMed ID: 6199090
[TBL] [Abstract][Full Text] [Related]
20. N-allylnormetazocine (SKF-10,047): the induction of feeding by a putative sigma agonist.
Gosnell BA; Levine AS; Morley JE
Pharmacol Biochem Behav; 1983 Nov; 19(5):737-42. PubMed ID: 6316372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
